LUTATHERA 370 MBq/mL sol perf 370 MBq 20.5-25 ml

7680697760017 CH-69776 V10XX04 17.02.
LUTATHERA 370 MBq/mL sol perf 370 MBq 20.5-25 ml
LUTATHERA 370 MBq/mL sol perf 370 MBq 20.5-25 ml
LUTATHERA 370 MBq/mL sol perf 370 MBq 20.5-25 ml
1 / 3
google

Details

GTIN
7680697760017
Pharmacode
-
Product number
6977601
CPT
-
Packaging group
20.5 - 25
Unit
ml
Composition
lutetium(177-Lu) oxodotreotidum 370 MBq, acidum aceticum, natrii acetas, acidum gentisicum, E 300, acidum diethylentriamin-pentakis(methylenphosphonicum), natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.24 mg.

Articles (1)

Lutathera 370 MBq/mL, Infusionslösung
Infusionslösung
20.5 - 25
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
lutetium(177-Lu) oxodotreotidum
370.0 MBQ Substance Wirkstoff (Principe actif)
acidum aceticum
- Substance HNIDK
natrii acetas
- Substance HNIDK
acidum gentisicum
- Substance Konservierungsstoff (Conservateur)
E 300
- Substance ANTON
acidum diethylentriamin-pentakis(methylenphosphonicum)
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
3.24 MG Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
69776
Drug name
Lutathera 370 MBq/ml, Infusionslösung
Galenic form
LSINF
ATC Code
V10XX04
Authorization status
Z
Dispensation category
A
First authorization
22/11/2024
Authorization expiration date
21/11/2029
IT number
17.02.
Domain
Human medicine
Field of application
Gastroenteropankreatische neuroendokrine Tumore (GEP-NET)

Packaging details

Description (FR)
LUTATHERA 370 MBq/mL sol perf 370 MBq 20.5-25 ml
Description (DE)
LUTATHERA 370 MBq/mL Inf Lös 370 MBq 20.5-25 ml
Market launch
22/11/2024
Narcotic (BTM)
No
Buy us a coffee Explore the data